Case series shows testosterone-lowering medication reduces problematic sexual behavior in males with intellectual disability, indicating a need for oversight.
Key Points
This research aims to explore the use and effects of testosterone-lowering medication (TLM) in patients with intellectual disabilities exhibiting problematic sexual behavior.
Nationwide survey conducted to identify patients with intellectual disability prescribed TLM.
Five male patients were included from specialized outpatient clinics.
Monitoring and access to treatment were assessed regionally.
Four out of five patients experienced reduced problematic sexual behavior during treatment.
Three patients relapsed after TLM was discontinued.
Adverse effects included osteoporosis, hypertension, depression, and suppressed sexual development.